Patents by Inventor Martina Jacobs

Martina Jacobs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ASSOCIATION OF EDG5 POLYMORPHISM V286A WITH TYPE II DIABETES MELLITUS AND VENOUS THROMBOSIS/PULMONARY EMBOLISM AND THE USE THEREOF
    Publication number: 20120208200
    Abstract: The present invention relates to a method of identifying an increase in risk for type II Diabetes mellitus, venous thrombosis, or pulmonary embolism in a subject, wherein the presence of an amino acid exchange at position 286 from valine (Val) to alanine (Ala) in the EDG5 protein in a biological sample taken from the subject.
    Type: Application
    Filed: April 27, 2012
    Publication date: August 16, 2012
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Detlef KOZIAN, Evi KOSTENIS, Karl-Ernst SIEGLER, Martina JACOBS, Jean-Francois DELEUZE, Sylvain RICARD, Sandrine MACE
  • Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof
    Patent number: 8198022
    Abstract: The present invention relates to a method of identifying an increase in risk for type II Diabetes mellitus, venous thrombosis, or pulmonary embolism in a subject, wherein the presence of an amino acid exchange at position 286 from valine (Val) to alanine (Ala) in the EDG5 protein in a biological sample taken from the subject.
    Type: Grant
    Filed: January 14, 2011
    Date of Patent: June 12, 2012
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Detlef Kozian, Evi Kostenis, Karl-Ernst Siegler, Martina Jacobs, Sylvain Ricard, Sandrine Mace, Jean-Francois Deleuze
  • ASSOCIATION OF EDG5 POLYMORPHISM V286A WITH TYPE II DIABETES MELLITUS AND VENOUS THROMBOSIS/PULMONARY EMBOLISM AND THE USE THEREOF
    Publication number: 20110104704
    Abstract: The present invention relates to a method of identifying an increase in risk for type II Diabetes mellitus, venous thrombosis, or pulmonary embolism in a subject, wherein the presence of an amino acid exchange at position 286 from valine (Val) to alanine (Ala) in the EDG5 protein in a biological sample taken from the subject.
    Type: Application
    Filed: January 14, 2011
    Publication date: May 5, 2011
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Detlef Kozian, Evi Kostenis, Karl-Ernst Siegler, Martina Jacobs, Jean-Francois Deleuze, Sylvain Ricard, Sandrine Mace
  • Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof
    Patent number: 7888020
    Abstract: The present invention relates to a method of identifying an increase in risk for type II Diabetes mellitus, venous thrombosis, or pulmonary embolism in a subject, wherein the presence of an amino acid exchange at position 286 from valine (Val) to alanine (Ala) in the EDG5 protein in a biological sample taken from the subject.
    Type: Grant
    Filed: August 7, 2007
    Date of Patent: February 15, 2011
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Detlef Kozian, Evi Kostenis, Karl-Ernst Siegler, Martina Jacobs, Sylvain Ricard, Sandrine Mace, Jean-Francois Deleuze
  • ASSOCIATION OF EDG5 POLYMORPHISM V286A WITH TYPE II DIABETES MELLITUS AND VENOUS THROMBOSIS/PULMONARY EMBOLISM AND THE USE THEREOF
    Publication number: 20070298509
    Abstract: The present invention relates to a method of identifying an increase in risk for type II Diabetes mellitus, venous thrombosis, or pulmonary embolism in a subject, wherein the presence of an amino acid exchange at position 286 from valine (Val) to alanine (Ala) in the EDG5 protein in a biological sample taken from the subject.
    Type: Application
    Filed: August 7, 2007
    Publication date: December 27, 2007
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Detlef KOZIAN, Evi KOSTENIS, Karl-Ernst STEGLER, Martina JACOBS, Jean-Francois DELEUZE, Sylvain RICARD, Sandrine MACE
  • Association of Protein Polymorphisms With Coronary Heart Disease
    Publication number: 20070292859
    Abstract: The invention concerns methods of identifying an increase in risk for coronary heart disease in an individual, wherein the presence of another amino acid than Glutaminic Acid at position 23 and/or the presence of another amino acid than Valine at position 337 in the Kir6.2 protein is determined in a sample. Moreover, probes, primers, polypeptides or polynucleotides suitable for said methods are claimed.
    Type: Application
    Filed: August 27, 2005
    Publication date: December 20, 2007
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Detlef Kozian, Heinz Goegelein, Karl-Ernst Siegler, Martina Jacobs, Jean-Francois Deleuze, Sylvain Ricard, Sandrine Mace
  • Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof
    Patent number: 7262273
    Abstract: The present invention relates to a method of identifying an increase in risk for type II Diabetes mellitus, venous thrombosis, or pulmonary embolism in a subject, wherein the presence of an amino acid exchange at position 286 from valine (Val) to alanine (Ala) in the EDG5 protein in a biological sample taken from the subject.
    Type: Grant
    Filed: March 21, 2003
    Date of Patent: August 28, 2007
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Detlef Kozian, Evi Kostenis, Karl-Ernst Siegler, Martina Jacobs, Jean-Francois Deleuze, Sylvain Ricard, Sandrine Mace
  • Association of EDG5 polymorphism V286A with type II Diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof
    Publication number: 20030219808
    Abstract: The present invention relates to a method of identifying an increase in risk for type II Diabetes mellitus, venous thrombosis, or pulmonary embolism in a subject, wherein the presence of an amino acid exchange at position 286 from valine (Val) to alanine (Ala) in the EDG5 protein in a biological sample taken from the subject.
    Type: Application
    Filed: March 21, 2003
    Publication date: November 27, 2003
    Inventors: Detlef Kozian, Evi Kostenis, Karl-Ernst Siegler, Martina Jacobs, Jean-Francois Deleuze, Sylvain Ricard, Sandrine Mace